Twitter Beğeni Hilesi

Observation of small (≤2cm) panc NETs is widely accepted and becoming a standard. Maybe it is a little more nuanced... Should we take into account tumor grade as well as stage re resection? Small G2 pNETs are more likely than G1 to be N+ (15% vs. 3%). sciencedirect.com/science/articl…

Our book, 'Acute Pancreatitis-A Practical Guide for Clinicians,' has been published by Springer Nature. Prof. John A Windsor & Prof. Anthony Phillips Uni of Auckland Flinders University. Thank u to our International super 🌟 friends & colleagues who contributed to the book

Thanks for your interest! 🙏🏻😉

Read Young BJS 'Acute threat of Life' series! 6⃣ Severe acute pancreatitis doi.org/10.1093/bjs/zn… - Severe acute pancreatitis is a potentially life-threatening condition that can cause multi-organ failure - Early initiation of supportive treatment and determination of severity

So you've decided to operate this IPMN? Now how to do it? Join Society of Surgical Oncology🌎 & E-AHPBA 🌍 panel of experts Ajay Maker Melissa Hogg Giovanni Marchegiani Marc Besselink 🔍Review challenging operative scenarios 🔍Ask your questions 📆 Sept 18 Get the link 👉🏻 ow.ly/YtBy50T2bKu

Julie Hallet Society of Surgical Oncology E-AHPBA Ajay Maker Melissa Hogg Giovanni Marchegiani Marc Besselink Kjetil Søreide Caitlin Hester Katie Duncan Patricio Polanco IHPBA The Pancreas Club YOUPPIE Pancreas Looking forward to the expert panel discussion on Sept 18

🚨Awaited prospective data for neoadjuvant in PNETs BJS Single arm preop PRRT for high-risk PNET 👥31 patients ✔️59% response rate ✔️path response exists 36% fibrosis ✔️M&M profile not altered Important step forward - congrats Stefano Partelli! 📝👇🏻

📝 in BJS 👉🏻 tinyurl.com/2abu5ny9 & editorial w Kjetil Søreide 👉🏻tinyurl.com/ycxwh5sn

Julie Hallet BJS Kjetil Søreide Very interesting work but the main question is: What are we trying to accomplish? Are long-term outcomes better? We need an RCT for that. What about long term risks? PRRT seems like a potentially valuable tool for downstaging and conversion of unresectable disease.

Thor Halfdanarson BJS Kjetil Søreide 💯 It's an important first step to move fwd with those questions. IMO, we now know 🔹Can get response with PRRT - rationale to study for downstaging 🔹Surgery safe after PRRT 🔹Don't miss a window for surgery with preop Rx 🔹Multi-centre prospective study of surgery in NETs can

Invited editorial AnnalsSurgOncology : Surgical Complications After Neoadjuvant Treatment for Borderline Resectable Pancreatic Cancer: From Benchmarks to Randomized Clinical Trials rdcu.be/dSIOH with PatrikLarsson Sanjay Pandanaboyana SoMe4HPB PanCAN E-AHPBA IHPBA Society of Surgical Oncology

Please read and respond to this survey by Tim Reese and Ernesto Sparrelid on FLR volumetry kn liver surgery 👇🏻 E-AHPBA SoMe4HPB IHPBA Liver Fellow Network Canadian Hepato-Pancreato-Biliary Association Moffitt Hepatobiliary

Neoadjuvant 177Lu-DOTATATE for non-functioning pancreatic neuroendocrine tumours (NEOLUPANET): multicentre phase II study ➡️ doi.org/10.1093/bjs/zn… 🏥NEOLUPANET was a multicentre, single-arm, phase II trial, conducted between March 2020 and February 2023 at eight Italian

The first prospective evidence on neoadjuvant RLT for pancreatic NET is finally out on BJS .Great team work from eight Italian centers 🇮🇹 ENETS NANETS NET Cancer Day Neuroendocrine Cancer UK #NotJustNECancer Neuroendocrine Cancer NET CANCER FOUNDATION NETs México NET Research Foundation NETwerk NET- ESPAÑA

Thanks Julie Hallet and Kjetil Søreide for this editorial on #neolupanet study

Read our Editorial by Kjetil Søreide and Niels Kok Curative-intent ablation margins (A0) for colorectal liver metastasis: more burning questions ➡️ doi.org/10.1093/bjs/zn… #SoMe4Surgery #MedTwitter #SurgEd #Surgery RCPSG Trainees' Committee aecirujanos SEIQ International Society of Surgery (ISS/SIC) #MedicalTechniques